Source: Benzinga

Pfizer: Upcoming Pfizer Earnings Call Might Be Focused On Tariffs, Policy Risks And Obesity Pipeline

Pfizer Inc (NYSE:PFE) is scheduled to release its first quarter 2025 earnings on 29 April. Latest Ratings for PFE DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Jan 2022Wells FargoMaintainsOverweight Jan 2022B of A SecuritiesUpgradesNeutralBuy View More Analyst Ratings for PFE View the Latest Analyst Ratings read more

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
Albert Bourla's photo - Chairman & CEO of Pfizer

Chairman & CEO

Albert Bourla

CEO Approval Rating

69/100

Read more